CXCR5 Inhibitors (Yale University)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCXCR5 Inhibitors (Yale University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-X-C motif chemokine receptor 5 antagonists
TargetsC-X-C motif chemokine receptor 5
Therapy Area/IndicationsAngioimmunoblastic T-cell Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesYale University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYale University
Active IndicationsN/A
Inactive IndicationsAngioimmunoblastic T-cell Lymphoma

Other Information

ATC CodeN/A
Related LinksN/A